DICE Study- Diastolic Improvement With Carvedilol & Empagliflozin in Patients With Cirrhosis
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 400 participants.
Also called NCT07322237
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 400 participants
- Registry
-
NCT07322237
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- India
- Registry status
- Recruiting
Technical summary
Registry record NCT07322237. Randomized; quadruple masking; primary purpose treatment. Start 2026-04-01 (actual); primary completion 2029-01-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- DICE Study- Diastolic Improvement With Carvedilol & Empagliflozin in Patients With Cirrhosis
- Acronym
- DICE
- Condition
- Cirrhotic Cardiomyopathy
- Condition
- Empagliflozin
- Condition
- Cardiometabolic Risk Factors
- Condition
- Cirrhosis
- Intervention (Drug)
- Empagliflozin + Carvedilol
- Intervention (Drug)
- Carvedilol
- Lead sponsor
- Post Graduate Institute of Medical Education and Research, Chandigarh
Record details
- Record id
cardio:ct-nct07322237- Content hash
35a30ab5cdc07f2be821113a454e4bb28832f7271a46c04e1eed2399e8e4ef2a